Locus Biosciences
Clinical phase American pharmaceutical company / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Locus Biosciences?
Summarize this article for a 10 year old
SHOW ALL QUESTIONS
Locus Biosciences is a clinical-stage pharmaceutical company, founded in 2015 and based in Research Triangle Park, North Carolina.[2] Locus develops phage therapies based on CRISPR–Cas3 gene editing technology, as opposed to the more commonly used CRISPR-Cas9, delivered by engineered bacteriophages.[5] The intended therapeutic targets are antibiotic-resistant bacterial infections.[1][5]
Quick Facts Company type, Industry ...
Company type | Privately held company |
---|---|
Industry | Pharmaceutical company |
Founded | May 22, 2015; 8 years ago (2015-05-22) in Raleigh, NC, USA |
Founders | |
Headquarters | Morrisville, North Carolina , United States |
Brands | crPhage |
Number of employees | 80[4] (2021) |
Website | www |
Close